Analysts See Over 50% Upside in Mid-Caps Like SPS Commerce, Maximus

An analysis of U.S. mid-capitalization stocks highlights several companies that analysts believe have significant upside potential, even as many have faced steep sell-offs over the past year. According to data from Investing.com, companies like SPS Commerce and Maximus lead a list where fair value estimates suggest potential gains of more than 50%, underscoring a sharp divergence between current market prices and analyst valuations.

Top Stocks by Upside Potential

The data shows a wide gap between analyst targets and recent stock performance, presenting a classic dilemma for investors weighing deep value against potential value traps. The most notable examples include:

• SPS Commerce Inc. (SPSC): Analysts see a 56.6% upside to its fair value, the highest on the list. This contrasts sharply with its -55.2% return over the past year.
• Maximus Inc. (MMS): The analysis points to a 52.1% potential upside, despite the stock declining 17.3% over the last 12 months.
• Harmony Biosciences (HRMY): This biotech firm is flagged for a 50.0% upside, following a more modest 5.9% decline in its share price.
• CNX Resources Corporation (CNX): The energy producer has a projected upside of 48.8% and is a performance outlier, having gained 10.3% over the past year.

Sector Performance and Analyst Commentary

The list reveals distinct sector-based trends and conflicting analyst views. In the energy sector, CNX Resources stands out with 53.5% revenue growth, and Truist Securities recently upgraded its rating on the stock to 'Hold' with a $35 price target, according to the report.

Ad

Conversely, SPS Commerce was downgraded by Morgan Stanley, which cited concerns over its valuation premium and the pace of expansion beyond its core business. In the healthcare space, Universal Health Services Inc. (UHS) is seen as an undervalued, steady performer with a 45.7% upside. UBS reiterated its 'Buy' rating for the hospital operator.

Market Context

The divergence in performance and outlook underscores the varied nature of the mid-cap segment, which sits between the perceived stability of large-caps and the high-growth potential of small-caps. Companies on the list range from high-growth technology and biotech firms to more defensive names in consumer staples and healthcare.

For example, fintech company PagSeguro Digital Ltd. is noted for its 49.2% upside and is backed by a 'Buy' rating from UBS. Meanwhile, Spectrum Brands Holdings Inc. (SPB), a consumer staples company, recently hit a 52-week high and has been engaging in aggressive share buybacks, with analysts seeing a 45.1% upside.